Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 tr...

Katherine R Tuttle <a class=“affiliation-link” title=“University of Washington, Seattle, WA, USA; Providence Inland Northwest Health, Spokane, WA, USA. Electronic address: katherine.tuttle@providence.org.” href=“https://pubmed.ncbi.nlm.nih.gov/38109916#full-view-a …